Uveal Melanoma: Diagnosis, Treatment Strategies and Optimizing Patient Care - Episode 6
Choosing the Appropriate Treatment for Metastatic Uveal Melanoma
August 23, 2024
Nathan L. Scott, M.D., provides a brief overview of the current guidelines for treatment of metastatic uveal melanoma, as well as what considerations go into choosing the appropriate treatment for it. This program was made possible with support from Immunocore.
Video content above is prompted by the following:
- Provide a brief overview of the current guidelines for the treatment of metastatic uveal melanoma.
- How has the approval of tebentafusp impacted the treatment landscape?
- How do you determine the right treatment for each patient?
- Provide a brief overview of the mechanism of action of tebentafusp. Which patients are eligible for this treatment?
- Why is it important for patients to know if they are HLA-A*02:01 positive?
- For patients not eligible for tebentafusp, what are your recommendations?
- As an advocate, how would you advise patients on how to approach selecting the best treatment option?
- What factors impact patients’ treatment selection, and what barriers do they face when selecting a treatment?
- How do you encourage patients to advocate for themselves when making decisions for their treatment?
- General query for these questions: Should they say the patient would work with their doctor to select best treatment for their situation?
Related Content:
